J. Ritter
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 61
- Hematopoietic Stem Cell Transplantation 15
- Chronic Myeloid Leukemia Treatments 12
- Infectious Diseases top 0.5%
-
- Acute Lymphoblastic Leukemia research 58
- Oncology top 1%
- Neutropenia and Cancer Infections 27
- Epidemiology top 1%
-
- Sarcoma Diagnosis and Treatment 18
-
- Blood disorders and treatments 13
-
- Neuroblastoma Research and Treatments 11
- Co-authors
- Stefan BielackUrsula CreutzigAlfred ReiterG. SchellongJochen HarbottMartin SchrappeF. CrokaertThomas F. Patterson
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
J. Ritter
163 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Hematology 2.5k
- Infectious Diseases 2.1k
- Public Health, Environmental and Occupational Health 2.5k
- Oncology 1.8k
- Epidemiology 2.2k
Countries citing papers authored by J. Ritter
This map shows the geographic impact of J. Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ritter more than expected).
Fields of papers citing papers by J. Ritter
This network shows the impact of papers produced by J. Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ritter. The network helps show where J. Ritter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Ritter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | User-friendly lemmatization and morphological annotation of Early New High German manuscripts. | 2014 | 0 |
| 2 | 2013 | 123 | |
| 3 | 2008 | 137 | |
| 4 | 2007 | 7 | |
| 5 | 2007 | 20 | |
| 6 | 2005 | 33 | |
| 7 | 1999 | 49 | |
| 8 | 1999 | 0 | |
| 9 | 1996 | 15 | |
| 10 | 1995 | 2 | |
| 11 | 1993 | 1 | |
| 12 | 1993 | 75 | |
| 13 | 1992 | 11 | |
| 14 | 1991 | 41 | |
| 15 | 1990 | 5 | |
| 16 | 1989 | 12 | |
| 17 | 1989 | 22 | |
| 18 | 1989 | 22 | |
| 19 | 1987 | 84 | |
| 20 | 1981 | 53 |
About J. Ritter
J. Ritter is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology, having authored 174 papers that have together received 8.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (61 papers), Acute Lymphoblastic Leukemia research (58 papers), Neutropenia and Cancer Infections (27 papers), Sarcoma Diagnosis and Treatment (18 papers), Hematopoietic Stem Cell Transplantation (15 papers), Blood disorders and treatments (13 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Neuroblastoma Research and Treatments (11 papers). The work is most often cited by research in Hematology (2.5k citations), Infectious Diseases (2.1k citations) and Public Health, Environmental and Occupational Health (2.5k citations). J. Ritter has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Stefan Bielack, Ursula Creutzig, Alfred Reiter, G. Schellong, Jochen Harbott, Martin Schrappe, F. Crokaert, Thomas F. Patterson, Ben de Pauw and Jacques Billé. Their work appears in journals such as Blood, British Journal of Haematology, Cancer, European Journal of Cancer and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.